Compare OVBC & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVBC | HUMA |
|---|---|---|
| Founded | 1872 | 2004 |
| Country | United States | United States |
| Employees | N/A | 184 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.5M | 191.4M |
| IPO Year | 1996 | N/A |
| Metric | OVBC | HUMA |
|---|---|---|
| Price | $42.90 | $0.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $6.19 |
| AVG Volume (30 Days) | 41.3K | ★ 5.5M |
| Earning Date | 04-28-2026 | 05-15-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | ★ 42.67 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $444.16 |
| Revenue Next Year | N/A | $248.39 |
| P/E Ratio | $47.13 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.00 | $0.55 |
| 52 Week High | $51.25 | $2.76 |
| Indicator | OVBC | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 45.84 | 50.41 |
| Support Level | $41.44 | $0.63 |
| Resistance Level | $43.26 | $0.87 |
| Average True Range (ATR) | 1.35 | 0.04 |
| MACD | 0.14 | 0.02 |
| Stochastic Oscillator | 34.87 | 95.11 |
Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services in Southeastern Ohio and western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers, and other standard banking products and services.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.